Tark Kim
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 5
- Epidemiology 24
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Co-authors
- Sang‐Ho Choi (26 shared papers)Eun Jung Lee (19 shared papers)Eun Ju Choo (28 shared papers)Sung‐Han Kim (23 shared papers)Jun Hee Woo (23 shared papers)Yang Soo Kim (24 shared papers)Tae Hyong Kim (19 shared papers)Sang‐Oh Lee (20 shared papers)
- Journals
- Journal of Korean Medical Science (5 papers)PLoS ONE (4 papers)Open Forum Infectious Diseases (4 papers)Infection Control and Hospital Epidemiology (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Tark Kim
66 papers receiving 1.3k citations
Tark Kim's Hit Papers
Peers
Comparison fields: 5 of 105
- Infectious Diseases 530
- Applied Microbiology and Biotechnology 44
- Modeling and Simulation 91
- Molecular Medicine 80
- Epidemiology 400
Countries citing papers authored by Tark Kim
This map shows the geographic impact of Tark Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tark Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tark Kim more than expected).
Fields of papers citing papers by Tark Kim
This network shows the impact of papers produced by Tark Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tark Kim. The network helps show where Tark Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Tark Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea Hit paper breakdown → | 2020 | 323 |
| 2 | 2011 | 63 | |
| 3 | 2009 | 61 | |
| 4 | 2017 | 52 | |
| 5 | 2013 | 49 | |
| 6 | 2022 | 41 | |
| 7 | 2012 | 37 | |
| 8 | 2018 | 35 | |
| 9 | 2012 | 33 | |
| 10 | 2013 | 32 | |
| 11 | 2024 | 31 | |
| 12 | 2014 | 31 | |
| 13 | 2014 | 28 | |
| 14 | 2019 | 25 | |
| 15 | 2012 | 23 | |
| 16 | 2020 | 23 | |
| 17 | 2017 | 21 | |
| 18 | 2009 | 21 | |
| 19 | 2014 | 20 | |
| 20 | 2016 | 19 |
About Tark Kim
Tark Kim is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Medicine and Neurology, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Antibiotic Resistance in Bacteria (7 papers), Streptococcal Infections and Treatments (6 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Long-Term Effects of COVID-19 (6 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Infectious Diseases (530 citations), Applied Microbiology and Biotechnology (44 citations), Modeling and Simulation (91 citations), Molecular Medicine (80 citations) and Epidemiology (400 citations). Tark Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Sang‐Ho Choi, Eun Jung Lee, Eun Ju Choo, Sung‐Han Kim, Jun Hee Woo, Yang Soo Kim, Tae Hyong Kim, Sang‐Oh Lee, Se Yoon Park and Mi‐Na Kim. Their work appears in journals such as Journal of Korean Medical Science, PLoS ONE, Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.